LONDON (Reuters) - The country’s medicines watchdog said Friday it had discovered a batch of counterfeit Novo Nordisk insulin pen needles circulating in the country and urged diabetics not to use them.
The counterfeit batch is Novofine Needles 31G (0.25mm x 6mm) with the lot number 08J02S, the Medicines and Healthcare Products Regulatory Agency (MHRA) said in a statement.
“The possible consequences of using these counterfeit needles could include adverse reactions; pain and discomfort; infection and difficulty in attaching the needle to the pen injection device,” it added.
The discovery is the latest example of fake medicines turning up in the supply chain and highlights the lucrative returns for criminals in passing off bogus treatments as genuine.
In recent years the MHRA has also found a number of counterfeit of batches of top-selling drugs, including Pfizer’s cholesterol fighter Lipitor and Sanofi-Aventis’ blood-thinner Plavix.
Reporting by Ben Hirschler; Editing by David Holmes
Our Standards: The Thomson Reuters Trust Principles.